325 related articles for article (PubMed ID: 37777791)
1. Receptor-interacting protein kinase 2 (RIPK2) profoundly contributes to post-stroke neuroinflammation and behavioral deficits with microglia as unique perpetrators.
Larochelle J; Tishko RJ; Yang C; Ge Y; Phan LT; Gunraj RE; Stansbury SM; Liu L; Mohamadzadeh M; Khoshbouei H; Candelario-Jalil E
J Neuroinflammation; 2023 Sep; 20(1):221. PubMed ID: 37777791
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic Benefits of Adropin in Aged Mice After Transient Ischemic Stroke via Reduction of Blood-Brain Barrier Damage.
Yang C; Liu L; Lavayen BP; Larochelle J; Gunraj RE; Butler AA; Candelario-Jalil E
Stroke; 2023 Jan; 54(1):234-244. PubMed ID: 36305313
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological inhibition of receptor-interacting protein kinase 2 (RIPK2) elicits neuroprotective effects following experimental ischemic stroke.
Larochelle J; Howell JA; Yang C; Liu L; Gunraj RE; Stansbury SM; de Oliveira ACP; Baksh S; Candelario-Jalil E
Exp Neurol; 2024 Jul; 377():114812. PubMed ID: 38729551
[TBL] [Abstract][Full Text] [Related]
4. Infiltrating myeloid cell-derived properdin markedly promotes microglia-mediated neuroinflammation after ischemic stroke.
Liu PY; Li HQ; Dong MQ; Gu XY; Xu SY; Xia SN; Bao XY; Xu Y; Cao X
J Neuroinflammation; 2023 Nov; 20(1):260. PubMed ID: 37951917
[TBL] [Abstract][Full Text] [Related]
5. A novel p55PIK signaling peptide inhibitor alleviates neuroinflammation via the STAT3/NF-kB signaling pathway in experimental stroke.
Liu Y; Leng C; Li Y; Zhou M; Ye X; Li C; Xia X; Sun B; Shu X; Liu W
J Stroke Cerebrovasc Dis; 2024 Jul; 33(7):107736. PubMed ID: 38679216
[TBL] [Abstract][Full Text] [Related]
6. SRGN amplifies microglia-mediated neuroinflammation and exacerbates ischemic brain injury.
Qian Y; Yang L; Chen J; Zhou C; Zong N; Geng Y; Xia S; Yang H; Bao X; Chen Y; Xu Y
J Neuroinflammation; 2024 Jan; 21(1):35. PubMed ID: 38287411
[TBL] [Abstract][Full Text] [Related]
7. Maraviroc, an inhibitor of chemokine receptor type 5, alleviates neuroinflammatory response after cerebral Ischemia/reperfusion injury via regulating MAPK/NF-κB signaling.
Chen B; Cao P; Guo X; Yin M; Li X; Jiang L; Shao J; Chen X; Jiang C; Tao L; Zhou L; Yu H
Int Immunopharmacol; 2022 Jul; 108():108755. PubMed ID: 35395466
[TBL] [Abstract][Full Text] [Related]
8. Lentivirus-mediated overexpression of OTULIN ameliorates microglia activation and neuroinflammation by depressing the activation of the NF-κB signaling pathway in cerebral ischemia/reperfusion rats.
Xu H; Qin W; Hu X; Mu S; Zhu J; Lu W; Luo Y
J Neuroinflammation; 2018 Mar; 15(1):83. PubMed ID: 29544517
[TBL] [Abstract][Full Text] [Related]
9. OTUD1 ameliorates cerebral ischemic injury through inhibiting inflammation by disrupting K63-linked deubiquitination of RIP2.
Zheng S; Li Y; Song X; Wu M; Yu L; Huang G; Liu T; Zhang L; Shang M; Zhu Q; Gao C; Chen L; Liu H
J Neuroinflammation; 2023 Nov; 20(1):281. PubMed ID: 38012669
[TBL] [Abstract][Full Text] [Related]
10. Microglial-specific depletion of TAK1 is neuroprotective in the acute phase after ischemic stroke.
Zeyen T; Noristani R; Habib S; Heinisch O; Slowik A; Huber M; Schulz JB; Reich A; Habib P
J Mol Med (Berl); 2020 Jun; 98(6):833-847. PubMed ID: 32382778
[TBL] [Abstract][Full Text] [Related]
11. Circular RNA PTP4A2 regulates microglial polarization through STAT3 to promote neuroinflammation in ischemic stroke.
Wang X; Zhang S; Lv B; Chen H; Zhang W; Dong L; Bao L; Wang M; Wang Y; Mao W; Cui L; Pang Y; Wang F; Yan F; Zhang Z; Cui G
CNS Neurosci Ther; 2024 Apr; 30(4):e14512. PubMed ID: 37869777
[TBL] [Abstract][Full Text] [Related]
12. Tat-NTS peptide protects neurons against cerebral ischemia-reperfusion injury via ANXA1 SUMOylation in microglia.
Zhou H; Yan L; Huang H; Li X; Xia Q; Zheng L; Shao B; Gao Q; Sun N; Shi J
Theranostics; 2023; 13(15):5561-5583. PubMed ID: 37908731
[No Abstract] [Full Text] [Related]
13. Gypenoside Pretreatment Alleviates the Cerebral Ischemia Injury via Inhibiting the Microglia-Mediated Neuroinflammation.
Xia X; Chen J; Ren H; Zhou C; Zhang Q; Cheng H; Wang X
Mol Neurobiol; 2024 Feb; 61(2):1140-1156. PubMed ID: 37688709
[TBL] [Abstract][Full Text] [Related]
14. TRIM45 causes neuronal damage by aggravating microglia-mediated neuroinflammation upon cerebral ischemia and reperfusion injury.
Xia Q; Zhan G; Mao M; Zhao Y; Li X
Exp Mol Med; 2022 Feb; 54(2):180-193. PubMed ID: 35217833
[TBL] [Abstract][Full Text] [Related]
15. Echinatin protects from ischemic brain injury by attenuating NLRP3-related neuroinflammation.
Sun L; Chen D; Zhao C; Hu Y; Xu Y; Xia S; Yang H; Bao X; Zhang Z; Zhou C; Zhang Q; Xu Y
Neurochem Int; 2024 May; 175():105676. PubMed ID: 38336256
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of Nogo-B ameliorates cerebral ischemia/reperfusion injury in mice through regulating microglia polarization via TLR4/NF-kappaB pathway.
Gong P; Jia HY; Li R; Ma Z; Si M; Qian C; Zhu FQ; Sheng-Yong L
Neurochem Int; 2023 Jul; 167():105553. PubMed ID: 37230196
[TBL] [Abstract][Full Text] [Related]
17. Electroacupuncture Alleviates Neuroinflammation by Regulating Microglia Polarization via STAT6/PPARγ in Ischemic Stroke Rats.
Yao Z; Cai L; Zhao A; Yang L; Chen Z; Zhang Y; Liang G; Luo M; Xu X; Zhou G
Neuroscience; 2023 Nov; 532():23-36. PubMed ID: 37741355
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effects of Aucubin against cerebral ischemia-reperfusion injury.
Liang Y; Chen L; Huang J; Lan Z; Xia S; Yang H; Bao X; Yu X; Fan Y; Xu Y; Zhu X; Jin J
Int Immunopharmacol; 2024 Mar; 129():111648. PubMed ID: 38335656
[TBL] [Abstract][Full Text] [Related]
19. Thymoquinone regulates microglial M1/M2 polarization after cerebral ischemia-reperfusion injury via the TLR4 signaling pathway.
Zhao B; Zhang S; Amin N; Pan J; Wu F; Shen G; Tan M; Shi Z; Geng Y
Neurotoxicology; 2024 Mar; 101():54-67. PubMed ID: 38325603
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effect of alpha-kinase 1 knockdown against cerebral ischemia through inhibition of the NF-κB pathway and neuroinflammation.
Li JY; Zheng ZX; Liu L; Du O; Yu NW; Zou Y; Seong SY; Du JR
Int Immunopharmacol; 2022 Dec; 113(Pt A):109330. PubMed ID: 36274483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
